![]() ![]() ![]() |
| FDA Home Page | CDRH Home Page | Search | A-Z Index | ![]() |
|
Given our current clinical knowledge and experience over the past several years, FDA is planning to revise this guidance. Please contact Elias Malis, Chief, Cardiac Electrophysiology and Monitoring Branch at 240 276-4080 or at elias.mallis@fda.hhs.gov, if you have comments or questions about the design of clinical studies for ventricular tachycardia ablation.
Updated September 26, 2006
![]()
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH